Latest Innovation News

Pioneer Lithium's Q4 2024 report highlights promising high-grade lithium assays at Root Lake, a key board appointment, and entry into Ontario's Junior Explorers Program, setting the stage for accelerated exploration.

Entyr Limited has ramped up tyre receivals and processing volumes in the December quarter, alongside securing new supply and offtake agreements as it prepares for ASX reinstatement. The company’s ongoing plant upgrades and strategic partnerships signal a potential turnaround in its operational and financial trajectory.

Volt Resources exceeded its graphite production goals in Q4 2024, producing over 800 tonnes at its Ukrainian Zavalievsky mine, while progressing development of its Tanzanian Bunyu Graphite Project and refining a novel US-based purification process.

Energy Action Limited reports a strong positive operating cash flow of $1.08 million in Q2 FY25, boosted by customer receipts and an R&D tax rebate, while advancing its AI-driven energy platform Utilibox to fuel future growth.

Energy Action Limited reported a positive net cash inflow from operating activities of $1.076 million for the December quarter, maintaining a solid cash position amid ongoing financing arrangements.

Tissue Repair Limited has commenced patient randomisation in its Phase 3 trial of TR987®, targeting chronic venous leg ulcers, aiming to confirm promising earlier results and potentially transform wound healing treatment.

Nuchev Limited has reported its first positive operating cashflow quarter alongside a 65% increase in revenue for the first half of FY25, driven by strong sales growth and the bWellness acquisition.

Redivium's Q2 FY25 report reveals strategic progress in lithium-ion battery recycling across Europe, including new partnerships and feasibility studies, while navigating tight cash reserves and a critical entitlement offer.

Opyl Limited's Q2 FY25 update reveals robust progress through key partnerships, a new AI Biotech Fund launch, and strengthened financial footing, positioning the company for expanded influence in clinical trial optimisation.

Altech Batteries Limited has made significant strides in funding and technology for its CERENERGY® battery project, including a $4 million capital raise and a breakthrough 55% increase in lithium-ion battery anode energy density.

Starpharma reports encouraging FDA feedback on its DEP® SN38 candidate for ovarian cancer and prepares for product launches in Saudi Arabia and UAE, supported by a solid $20.3 million cash position.

NoviqTech has entered a strategic partnership with Evercity to integrate their platforms and expand blockchain-enabled carbon market solutions, targeting emerging markets like East Africa.